These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 38162440)
21. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum. Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917 [TBL] [Abstract][Full Text] [Related]
22. Satralizumab might not be enough. Olamkicept (sgp130Fc) in Neuromyelitis Optica Spectrum Disorder. Magro G Mult Scler Relat Disord; 2022 Sep; 65():104037. PubMed ID: 35835028 [TBL] [Abstract][Full Text] [Related]
29. Olamkicept(sgp130Fc): The missing trial in Neuromyelitis Optica Spectrum Disorder. Magro G Clin Immunol; 2022 Aug; 241():109072. PubMed ID: 35798242 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of effect of empirical attack-preventive immunotherapies in neuromyelitis optica spectrum disorders: An update systematic review and meta -analysis. Ma J; Yu H; Wang H; Zhang X; Feng K J Neuroimmunol; 2022 Feb; 363():577790. PubMed ID: 34959021 [TBL] [Abstract][Full Text] [Related]
31. Targeting IL-6 receptor in the treatment of neuromyelitis optica spectrum: a review of emerging treatment options. Rosso M; Saxena S; Chitnis T Expert Rev Neurother; 2020 May; 20(5):509-516. PubMed ID: 32306778 [No Abstract] [Full Text] [Related]
33. Initiation of rituximab therapy for new onset neuromyelitis optica spectrum disorder during pregnancy. Munger KC; Samkoff LM Mult Scler Relat Disord; 2020 Jan; 37():101442. PubMed ID: 32173005 [TBL] [Abstract][Full Text] [Related]
34. Different clinical phenotypes of AQP4-IgG positive NMOSD in two first degree relatives. Ssemmanda S; Musubire AK BMC Neurol; 2023 Sep; 23(1):315. PubMed ID: 37667215 [TBL] [Abstract][Full Text] [Related]
35. Tryptophan immunoadsorption during pregnancy and breastfeeding in patients with acute relapse of multiple sclerosis and neuromyelitis optica. Hoffmann F; Kraft A; Heigl F; Mauch E; Koehler J; Harms L; Kümpfel T; Köhler W; Ehrlich S; Bayas A; Weinmann-Menke J; Beuker C; Henn KH; Ayzenberg I; Ellrichmann G; Hellwig K; Klingel R; Fassbender CM; Fritz H; Slowinski T; Weihprecht H; Brand M; Stiegler T; Galle J; Schimrigk S Ther Adv Neurol Disord; 2018; 11():1756286418774973. PubMed ID: 29872456 [TBL] [Abstract][Full Text] [Related]
36. Efficacy and Safety of Monoclonal Antibody Therapy in Neuromyelitis Optica Spectrum Disorders: Evidence from Randomized Controlled Trials. Xue T; Yang Y; Lu Q; Gao B; Chen Z; Wang Z Mult Scler Relat Disord; 2020 Aug; 43():102166. PubMed ID: 32442886 [TBL] [Abstract][Full Text] [Related]
37. Neuromyelitis Optica Spectrum Disorder: A Rare Case of Transverse Myelitis and Autonomic Dysfunction. Bugshan TF; Asiri M; Alqahtani M; Maghrabi R; Alotaibi HS; Alharbi N Cureus; 2023 May; 15(5):e38791. PubMed ID: 37303442 [TBL] [Abstract][Full Text] [Related]
39. Recurrent optic neuritis in a patient with Sjogren syndrome and neuromyelitis optica spectrum disorder: A case report. Zheng W; Liu X; Hou X; Zhu Y; Zhang T; Liao L Medicine (Baltimore); 2020 Nov; 99(45):e23029. PubMed ID: 33157952 [TBL] [Abstract][Full Text] [Related]
40. Advances in the Treatment of Neuromyelitis Optica Spectrum Disorder. Wallach AI; Tremblay M; Kister I Neurol Clin; 2021 Feb; 39(1):35-49. PubMed ID: 33223088 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]